Ignite Creation Date:
2025-12-24 @ 7:48 PM
Ignite Modification Date:
2026-06-02 @ 3:55 AM
Study NCT ID:
NCT01765803
Status:
TERMINATED
Last Update Posted:
2016-04-14
First Post:
2013-01-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Feasibility of Thioridazine as a Mobilizing Agent for CD34+ Hematopoietic Progenitor Cells
Sponsor:
New Mexico Cancer Research Alliance
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Healthy Subjects | View |